EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Globus Medical's enterprise value is $6,846 Mil.
Globus Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1,568 Mil. Therefore, Globus Medical's EV-to-Revenue for today is 4.36.
The historical rank and industry rank for Globus Medical's EV-to-Revenue or its related term are showing as below:
GMED'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.04 Med: 5.05 Max: 9.12
Current: 4.36
During the past 13 years, the highest EV-to-Revenue of Globus Medical was 9.12. The lowest was 3.04. And the median was 5.05.
GMED's EV-to-Revenue is ranked worse than 61.97% of 823
companies
in the Medical Devices & Instruments industry
Industry Median: 3.16
vs GMED: 4.36
As of today (2024-04-30), Globus Medical's stock price is $50.61.
Globus Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $13.37. Therefore, Globus Medical's PS Ratio for today is 3.79.
Globus Medical EV-to-Revenue Historical Data
The historical data trend for Globus Medical's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Globus Medical's EV-to-Revenue
For the Medical Devices subindustry, Globus Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Globus Medical's EV-to-Revenue falls into.
Globus Medical's current Enterprise Value is $6,846 Mil.
Globus Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,568 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical (NYSE:GMED) EV-to-Revenue Explanation
Globus Medical's share price for today is $50.61.
Globus Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.37.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Globus Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Globus Medical (Globus Medical) Business Description
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GMED has been successfully added to your 